Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

BioRestorative Therapies (BRTX) Equity Ratio (2016 - 2025)

Historic Equity Ratio for BioRestorative Therapies (BRTX) over the last 15 years, with Q3 2025 value amounting to 0.39.

  • BioRestorative Therapies' Equity Ratio fell 4295.37% to 0.39 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.39, marking a year-over-year decrease of 4295.37%. This contributed to the annual value of 0.69 for FY2024, which is 1241.84% down from last year.
  • According to the latest figures from Q3 2025, BioRestorative Therapies' Equity Ratio is 0.39, which was down 4295.37% from 0.57 recorded in Q2 2025.
  • Over the past 5 years, BioRestorative Therapies' Equity Ratio peaked at 0.96 during Q4 2021, and registered a low of 2.24 during Q3 2021.
  • Moreover, its 5-year median value for Equity Ratio was 0.6 (2025), whereas its average is 0.28.
  • In the last 5 years, BioRestorative Therapies' Equity Ratio skyrocketed by 41402.58% in 2021 and then tumbled by 6819.42% in 2023.
  • BioRestorative Therapies' Equity Ratio (Quarter) stood at 0.96 in 2021, then plummeted by 34.9% to 0.63 in 2022, then grew by 26.69% to 0.79 in 2023, then fell by 12.42% to 0.69 in 2024, then tumbled by 43.7% to 0.39 in 2025.
  • Its last three reported values are 0.39 in Q3 2025, 0.57 for Q2 2025, and 0.6 during Q1 2025.